BrainStorm Cell Therapeutics
BCLI
#10765
Rank
โ‚ฌ8.71 M
Marketcap
0,79ย โ‚ฌ
Share price
-9.73%
Change (1 day)
23.30%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚ฌ0.66 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total assets are โ‚ฌ0.66 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BrainStorm Cell Therapeutics - Total assets on balance sheet (from 2002 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ0.86 M-50.58%
2024-12-31โ‚ฌ1.76 M-53.75%
2023-12-31โ‚ฌ3.8 M-51.68%
2022-12-31โ‚ฌ7.87 M-69.52%
2021-12-31โ‚ฌ25.85 M-37.97%
2020-12-31โ‚ฌ41.67 M614.49%
2019-12-31โ‚ฌ5.83 M-40.57%
2018-12-31โ‚ฌ9.81 M3.09%
2017-12-31โ‚ฌ9.52 M-6.99%
2016-12-31โ‚ฌ10.23 M-34.48%
2015-12-31โ‚ฌ15.62 M91.69%
2014-12-31โ‚ฌ8.14 M138.13%
2013-12-31โ‚ฌ3.42 M-11.9%
2012-12-31โ‚ฌ3.88 M83.83%
2011-12-31โ‚ฌ2.11 M158.08%
2010-12-31โ‚ฌ0.81 M54.95%
2009-12-31โ‚ฌ0.52 M-15.58%
2008-12-31โ‚ฌ0.62 M-15.62%
2007-12-31โ‚ฌ0.74 M35.37%
2006-12-31โ‚ฌ0.54 M
2006-03-31โ‚ฌ0.71 M5.34%
2005-03-31โ‚ฌ0.68 M5090.06%
2004-03-31โ‚ฌ0.01 M-68.76%
2003-03-31โ‚ฌ0.04 M-42.4%
2002-03-31โ‚ฌ0.07 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
โ‚ฌ25.87 B 3,904,946.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ49.39 B 7,453,939.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ3.18 B 481,258.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ1.11 B 168,572.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.16 B 24,596.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA